Fauci has ‘rebound’ COVID after Paxlovid treatment
Jun 30, 2022
The director of the NIAID says the drug kept him out of the hospital, however.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
Fatigue, brain fog, anxiety prevalent with long COVID
Jun 28, 2022
Significant associations were seen for concentration and attention, as well as memory issues, with the complaint of brain fog.
Little difference seen in weight changes before, after COVID-19 shutdown
Jun 16, 2022
Significant increases were seen in weight during preshutdown and postshutdown years, but no significant difference was noted between the two.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.
Multisystem abnormalities persist after COVID-19 hospitalization
May 31, 2022
Persisting evidence of cardio-renal involvement and hemostasis pathway activation was reported at 28 to 60 days after discharge.
COVID-19 can ‘rebound’ after treatment with Paxlovid, CDC says
May 24, 2022
In these cases, the illness improved or resolved within an average of three days.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
Loss of smell, taste less likely with newer COVID-19 variants
May 18, 2022
A lower risk for developing chemosensory loss was observed with the alpha, delta and omicron variants.